Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

European Psychiatry

Volumn 22, Issue 8, 2007, Pages 490-498

  San, Luis ^a   Ciudad, Antonio ^b   Álvarez, Enrique ^c   Bobes, Julio ^d   Gilaberte, Inmaculada ^b  

^a HOSPITAL SAN RAFAEL   (Spain)

^b ELI LILLY AND COMPANY   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Cross sectional studies; Recovery; Remission; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; MONOTHERAPY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT ATTITUDE; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RATING SCALE; REMISSION; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL INTERACTION;

ACTIVITIES OF DAILY LIVING; ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REHABILITATION, VOCATIONAL; RETREATMENT; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; SPAIN; SUBSTANCE-RELATED DISORDERS;

EID: 36048974467     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.06.005     Document Type: Article

References (36)

1. Alvarez E., Ciudad A., Olivares J.M., Bousono M., and Gomez J.C. randomized A: A1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia. J Clin Psychopharmacol 26 (2006) 238-249
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (2000), American Psychiatric Association, Washington, DC
3. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 39 (1982) 784-788
4. Andreasen N.C. Positive vs. negative schizophrenia: a critical evaluation. Schizophr Bull 11 (1985) 380-389
5. Andreasen N.C., Carpenter Jr. W.T., Kane J.M., Lasser R.A., Marder S.R., et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162 (2005) 441-449
6. Andreasen N.C., and Olsen S. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 39 (1982) 789-794
7. Birchwood M., Mason R., MacMillan F., and Healy J. Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 23 (1993) 387-395
8. Cannon-Spoor H.E., Potkin S.G., and Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8 (1982) 470-484
9. Ciudad A., Prieto L., Olivares J.M., Montejo A.L., Ros S., and Novick D. The European schizophrenia outpatient health outcomes (SOHO) study: baseline findings of the Spanish sample. Actas Esp Psiquiatr 32 (2004) 227-235
10. Docherty J.P., Bossie C.A., Lachaux B., Bouhours P., Zhu Y., Lasser R., et al. Patient-based and clinician-based support for the remission criteria in schizophrenia. Int Clin Psychopharmacol 22 (2007) 51-55
11. Emsley R., Oosthuizen P.P., Kidd M., Koen L., Niehaus D.J., and Turner H.J. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 67 (2006) 1707-1712
12. Emsley R., Rabinowitz J., and Medori R. Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates. Schizophr Res 89 (2007) 129-139
13. Helldin L., Kane J.M., Karilampi U., Norlander T., and Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res 40 (2006) 738-745
14. Hogan T.P., and Awad A.G. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22 (1992) 347-352
15. Kohler C.G., and Lallart E.A. Postpsychotic depression in schizophrenia patients. Curr Psychiatry Rep 4 (2002) 273-278
16. Lambert M., Schimmelmann B.G., Naber D., Schacht A., Karow A., Wagner T., et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 67 (2006) 1690-1697
17. Lasser R.A., Bossie C.A., Gharabawi G.M., and Kane J.M. Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection. Schizophr Res 77 (2005) 215-227
18. Leucht S., and Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 39 (2006) 161-170
19. Liberman R.P., and Kopelowicz A. Recovery from schizophrenia: a challenge for the 21st century. Int Rev Psychiatry 14 (2002) 245-255
20. Liberman R.P., Kopelowicz A., Ventura J., and Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry 14 (2002) 256-272
21. Lopez-Garcia E., Banegas J.R., Graciani Perez-Regadera A., Gutierrez-Fisac J.L., Alonso J., and Rodriguez-Artalejo F. Population-based reference values for the Spanish version of the SF-36 Health Survey in the elderly. Med Clin (Barc) 120 (2003) 568-573
22. Lublin H., Eberhard J., and Levander S. Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics. Int Clin Psychopharmacol 20 (2005) 183-198
23. Mandel M.R., Severe J.B., Schooler N.R., Gelenberg A.J., and Mieske M. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry 39 (1982) 197-203
24. Ott S.L., Spinelli S., Rock D., Roberts S., Amminger G.P., and Erlenmeyer-Kimling L. The New York High-Risk Project: social and general intelligence in children at risk for schizophrenia. Schizophr Res 31 (1998) 1-11
25. Perkins D., Lieberman J., Gu H., Tohen M., McEvoy J., Green A., et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 185 (2004) 18-24
26. Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., and Bilder R.M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161 (2004) 473-479
27. Rosenheck R.A., Leslie D.L., Sindelar J., Miller E.A., Lin H., Stroup T.S., et al. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Am J Psychiatry 163 (2006) 2080-2089
28. Sanjuan J., Prieto L., Olivares J.M., Ros S., Montejo A., Ferrer F., et al. GEOPTE Scale of social cognition for psychosis. Actas Esp Psiquiatr 31 (2003) 120-128
29. Strauss J.S., and Carpenter Jr. W.T. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry 31 (1974) 37-42
30. Swartz M.S., Perkins D.O., Stroup T.S., Davis S.M., Capuano G., Rosenheck R.A., et al. Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study. Am J Psychiatry 164 (2007) 428-436
31. Swartz M.S., Wagner H.R., Swanson J.W., Stroup T.S., McEvoy J.P., McGee M., et al. Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study. Psychiatr Serv 57 (2006) 1110-1116
32. van Mastrigt S., and Addington J. Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 27 (2002) 92-101
33. van Os J., Burns T., Cavallaro R., Leucht S., Peuskens J., Helldin L., et al. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 113 (2006) 91-95
34. van Os J., Drukker M., a Campo J., Meijer J., Bak M., and Delespaul P. Validation of remission criteria for schizophrenia. Am J Psychiatry 163 (2006) 2000-2002
35. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
36. Zimmerman M., Posternak M.A., and Chelminski I. Defining remission on the Montgomery-Asberg depression rating scale. J Clin Psychiatry 65 (2004) 163-168